Stem Cell Therapy against COVID-19
Author(s): Sarbesh Kumar Jha, Atul Dwivedi*, Praveen Kumar, Deepak Sigdel, Den Prasad Achary, Roshan Khadka, Xiaoming Qiu and Shweta Shukla Dwivedi
Abstract
The term corona virus (Latin: Corona, crown) is coined due to presence of spikes glycoproteins on the surface that gives it a crown-like appearance. Coronaviruses came from the family Coronaviridae and the order Nidovirales. Novel Corona Virus Disease outbreak happened in January 2020 subsequently dispersed around the world and reason for death of several million people worldwide. Currently, no effective treatment for severe COVID-19 patients is present. Now days, patients are only treated symptomatically. Scientific community working to develop novel antiviral drugs, vaccines, immunomodulatory medications. In the recent scenario of COVID-19 pandemic, we lack any better therapeutic option for treatment of severe COVID-19 patients. MSCs may be a better option for providing emergency therapy. Vast number of studies and clinical trials are warranted regarding the safety and efficacy stem cell therapy in COVID-19 and other respiratory disorders.